The following is a summary of “A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland,” published in the April ...

by measuring IgA and IgG antibodies and virus neutralizing antibodies in volunteers with existing high levels of IgG antibodies against SARS-CoV-2. Administration of the Avacc 10 ® vaccine was ...

This month marks five years since the COVID-19 pandemic began. The SARS-CoV-2 virus was circulating for months, likely ...

A study headed by researchers at the Applied Biomedical Science Institute and collaborators have uncovered a region of the SARS-CoV-2 virus spike protein that induces potentially pathogenic ...

Pregnant women who contract SARS-CoV-2 may have a lower risk of developing Long COVID than matched non-pregnant women.

"Regular vaccine updates are critical for renewing ... More information: Hiam Chemaitelly et al, Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron, Nature (2025).

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could ...

Other mRNA vaccines or vaccine types, such as vector- or protein ... to fully address the long-term burdens caused by ...

SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome) are serious infectious respiratory diseases that are caused by members of a class of viruses known as coronaviruses ...